Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|May 12, 2020
Psychosocial Associations Between Xenophobia and COVID-19
Author(s)Renato D. Alarcón, MD, MPH
We are seeing a rise in hatred and lack of empathy in the face of COVID-19.
Advertisement
Renato D. Alarcón, MD, MPH, talks about two important volumes he reviewed in Psychiatric Times,
Dr Alarcón is Emeritus Professor of Psychiatry, Mayo Clinic School of Medicine, Rochester, MN; Honorio Delgado Chair, Universidad Peruana Cayetano Heredia, Lima, Perú. He is an editorial board member of Psychiatric Times.
Advertisement
Related to this article
Adjustment disorder often goes undiagnosed after major life stressors, especially in cancer care; learn updated criteria, risks, and emerging therapies like psilocybin.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
Schizophrenia: A Telltale of the Brain’s Complexity
3
Podcast: Interventional Psychiatry and the Challenge of Difficult-to-Treat Depression
4
Talking With Titans: Sheldon Preskorn, MD, on the Evolution of Psychopharmacology
5